✦ LIBER ✦
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses
✍ Scribed by Kenji Tamura; Kazuhiko Nakagawa; Takayasu Kurata; Taroh Satoh; Toshiji Nogami; Koji Takeda; Shigeki Mitsuoka; Naruo Yoshimura; Shinzoh Kudoh; Shunichi Negoro; Masahiro Fukuoka
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 342 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.